Delivery Order SPE2DE24D0013-SPE2D625F2LQF

The Defense Department's Medical Supply Chain awarded a $17,280 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 3, 2025, with completion targeted for September 10, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, carries no set-aside designation and procures diagnostic testing solutions, likely reagents and assays for COVID-19, influenza, and respiratory syncytial virus detection based on the contract identifier. The award leverages Cepheid's specialized expertise in point-of-care and laboratory molecular diagnostic systems, which the company has consistently delivered across federal healthcare systems including the Department of Veterans Affairs and Defense Logistics Agency.

This delivery order is likely issued under one of Cepheid's existing indefinite delivery vehicles with the VA, most notably the $32.8 billion single-award IDV established with VA's Veterans Integrated Service Network 6, which provides molecular diagnostic testing system reagents and assays through September 2030. The Medical Supply Chain's reliance on Cepheid's GeneXpert platform and associated reagents aligns with the company's broader role in supporting federal infectious disease diagnostic capabilities across military and veteran healthcare networks, enabling rapid identification and treatment of respiratory pathogens and other clinical conditions.